Artificial intelligence for post-treatment prediction in age-related macular degeneration

Read full text Summarise with VIRAT
Authors: Chia-Ying Tsai, Tso‐Ting Lai
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Ophthalmology pioneered the clinical use of artificial intelligence (AI). Beyond automating routine tasks, including retinal disease screening via fundus photography and optical coherence tomography (OCT),1,2 AI now excels at complex challenges such as sex differentiation based on OCT images,3 which often eludes even human experts. Building on earlier breakthroughs in ophthalmology, Xinyu Zhao and colleagues4 advanced the use of AI in the field. Their KongMing Model, published in The Lancet Digital Health, uses a novel structural attention-guided therapeutic response predicting model that successfully predicted both anatomical and functional changes in patients with neovascular age-related macular degeneration (nAMD) treated with conbercept (an anti-vascular endothelial growth factor [anti-VEGF]).

Fields of Study & Subjects

Retinal Imaging and Analysis Retinal Diseases and Treatments Artificial Intelligence in Healthcare and Education

Publication details

Journal / source
The Lancet Digital Health
Volume
8
Issue
4
Pages
100997–100997
Publication date
26 March 2026
Language
EN